- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05949801
Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial Based on Standard Treatment to Evaluate the Effect of Injectable Neucardin on Cardiac Function and Reverse Ventricular Remodeling in Patients With Chronic Systolic Heart Failure
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This trial is planned to be conducted simultaneously in multiple clinical study sites nationwide, including 198 subjects, 99 subjects in the treatment group and 99 subjects in the placebo group.
Primary endpoint:
1.Response rate at 35 days of simultaneous reduction of LVESVI and LVEDVI by more than or equal to 20 ml/m2 (The proportion of the subjects achieving this criterion in each treatment group.)
Secondary endpoints:
- Response rate at 35 day of LVESVI improvement greater than or equal to 25 ml/m2 ;
- Response rate at 35 day of LVEDVI improvement greater than or equal to 25 ml/m2 ;
- Change from baseline in LVEF, LVESV, LVEDV, LVESVI and LVEDVI at 35 days ;
- 90-day response rate of LVESVI improved greater than or equal to 25ml/m2,LVEDVI improved greater than or equal to 25 ml/m2, and LVESVI and LVEDVI improved greater than or equal to 20 ml/m2 at the same time ;
- Change from baseline in LVEF, LVESV, LVEDV, LVESVI and LVEDVI at 90 days ;
- Change from baseline in NYHA at 35 and 90 days ;
- Change from baseline in quality of life at 35 and 90 days ;
- Mortality during the study period.
Study Type
Enrollment (Estimated)
Phase
- Phase 3
Contacts and Locations
Study Contact
- Name: Xiaoyan Qin, ph.D
- Phone Number: 138 86-021-50802627
- Email: qinxiaoyan@zensun.com
Study Locations
-
-
Beijing
-
Beijin, Beijing, China, 100037
- Active, not recruiting
- Fuwai Hospital Chinese Academy of Medical Sciences
-
Beijing, Beijing, China, 100037
- Active, not recruiting
- Beijing Chao-Yang Hospital , Capital Medical University
-
Beijing, Beijing, China
- Active, not recruiting
- Beijing Anzhen Hospital , Capital Medical University
-
Beijing, Beijing, China
- Active, not recruiting
- Beijing Friendship Hospital , Capital Medical University
-
Beijing, Beijing, China
- Active, not recruiting
- Peking University First Hospital
-
Beijing, Beijing, China
- Active, not recruiting
- Peking university People's Hospital
-
Beijing, Beijing, China
- Active, not recruiting
- The First Medical Center of General Hospital of Chinese People's Liberation Army
-
Beijing, Beijing, China
- Active, not recruiting
- Chinese people's liberation army general hospital No.6 medical center
-
-
Chongqing
-
Chongqing, Chongqing, China
- Active, not recruiting
- Chongqing Emergency Medical Center (Chongqing Fourth People's Hospital)
-
Chongqing, Chongqing, China
- Active, not recruiting
- Chongqing University Three Gorges Hospital
-
-
Fujian
-
Longyan, Fujian, China
- Active, not recruiting
- Longyan First Hospital
-
Xiamen, Fujian, China
- Active, not recruiting
- Xiamen Cardiovascular Hospital Xiamen University
-
-
Guangdong
-
Guangzhou, Guangdong, China
- Active, not recruiting
- First Affiliated Hospital of Sun Yat-sen University
-
Jieyang, Guangdong, China
- Active, not recruiting
- Guangdong Jieyang People's Hospital
-
Maoming, Guangdong, China
- Active, not recruiting
- Maoming People's Hospital
-
-
Guangxi Zhuang Autonomous Region
-
Liuzhou, Guangxi Zhuang Autonomous Region, China
- Active, not recruiting
- Liuzhou Worker's Hospital
-
Nanning, Guangxi Zhuang Autonomous Region, China
- Active, not recruiting
- People's Hospital of Guangxi Zhuang Autonomous Region
-
-
Hainan
-
Haikou, Hainan, China
- Active, not recruiting
- Haikou People's Hospital
-
Haikou, Hainan, China
- Active, not recruiting
- Hainan Provincial People's Hospital
-
-
Hebei
-
Baoding, Hebei, China
- Active, not recruiting
- Affiliated Hospital of Hebei University
-
Shijiazhuang, Hebei, China
- Active, not recruiting
- The First Hospital of Hebei Medical University
-
-
Heilongjiang
-
Daqing, Heilongjiang, China
- Active, not recruiting
- Daqing Oilfield General Hospital
-
Ha'erbin, Heilongjiang, China
- Active, not recruiting
- The First Affiliated Hospital Of Harbin Medical University
-
Qiqihar, Heilongjiang, China
- Active, not recruiting
- Qiqihar first hospital
-
-
Henan
-
Anyang, Henan, China
- Active, not recruiting
- Anyang People's Hospital (Anyang Central Hospital)
-
Kaifeng, Henan, China
- Active, not recruiting
- Huaihe Hospital of Henan University
-
Luoyang, Henan, China
- Active, not recruiting
- First Affiliated Hospital of Henan University of Science and Technology
-
Luoyang, Henan, China
- Active, not recruiting
- Luoyang Central Hospital
-
Nanyang, Henan, China
- Active, not recruiting
- NanYang First people's hospital
-
Nanyang, Henan, China
- Active, not recruiting
- Nanyang Central Hospital
-
Puyang, Henan, China
- Active, not recruiting
- General Hospital of Puyang Oilfield
-
Sanmenxia, Henan, China
- Active, not recruiting
- Sanmenxia Central Hospital
-
Shangqiu, Henan, China
- Active, not recruiting
- First People's Hospital of Shangqiu
-
Xinxiang, Henan, China
- Active, not recruiting
- The First Affiliated Hospital of Xinxiang Medical College
-
Xinxiang, Henan, China
- Active, not recruiting
- Xinxiang Central Hospital
-
Zhengzhou, Henan, China
- Active, not recruiting
- First Affiliated Hospital of Zhengzhou University
-
Zhengzhou, Henan, China
- Active, not recruiting
- The First Affiliated Hospital of Henan University
-
Zhumadian, Henan, China
- Active, not recruiting
- Zhumadian Central Hospital
-
-
Huanan
-
Chenzhou, Huanan, China
- Active, not recruiting
- Chenzhou First People's Hospital
-
-
Hubei
-
Wuhan, Hubei, China
- Active, not recruiting
- People's Hospital of Wuhan University
-
Wuhan, Hubei, China
- Active, not recruiting
- Zhongnan Hospital of Wuhan University
-
Wuhan, Hubei, China
- Active, not recruiting
- Wuhan Wuchang Hospital
-
Xiangyang, Hubei, China
- Active, not recruiting
- Xiangyang Central Hospital
-
Xiangyang, Hubei, China
- Active, not recruiting
- Xiangyang first people's hospital
-
-
Hunan
-
Changsha, Hunan, China
- Active, not recruiting
- People's Hospital of Hunan Provincial
-
Hengyang, Hunan, China
- Active, not recruiting
- South China University Affiliated South China Hospital
-
Hengyang, Hunan, China
- Active, not recruiting
- The Second Affiliated Hospital of Nanhua University
-
Yueyang, Hunan, China
- Active, not recruiting
- Yueyang Central Hospital
-
-
Jiangxi
-
Nanchang, Jiangxi, China
- Active, not recruiting
- Jiangxi Provincial People's Hospital
-
-
Jiansu
-
Changzhou, Jiansu, China
- Recruiting
- Changzhou No.2 People's Hospital
-
Contact:
- Yuan Ji, M.D
-
Changzhou, Jiansu, China
- Active, not recruiting
- The First People's Hospital of Changzhou
-
Huai'an, Jiansu, China
- Active, not recruiting
- Huai'an First People's Hospital
-
Nanjing, Jiansu, China
- Active, not recruiting
- The Second Affiliated Hospital of Nanjing Medical University
-
Nanjing, Jiansu, China
- Active, not recruiting
- Zhongda Hospital Southeast University
-
Suzhou, Jiansu, China
- Active, not recruiting
- The First Affiliated Hospital of Soochow University
-
Suzhou, Jiansu, China
- Active, not recruiting
- The Suzhou Municipal Hospital
-
Xuzhou, Jiansu, China
- Active, not recruiting
- Affiliated Hospital of Xuzhou Medical University
-
Xuzhou, Jiansu, China
- Active, not recruiting
- Xuzhou Central Hospital
-
Yangzhou, Jiansu, China
- Active, not recruiting
- Subei People's Hospital
-
-
Jilin
-
Changchun, Jilin, China
- Active, not recruiting
- China-Japan Union Hospital of Jilin University
-
Changchun, Jilin, China
- Active, not recruiting
- Jilin University Second Hospital
-
Changchun, Jilin, China
- Active, not recruiting
- The First Hospital of Jilin University
-
-
Liaoning
-
Anshan, Liaoning, China
- Active, not recruiting
- Ansteel Group Genral Hospital
-
Benxi, Liaoning, China
- Active, not recruiting
- Benxi Central Hospital
-
Dalian, Liaoning, China
- Active, not recruiting
- The First Affiliated Hospital of Dalian Medical University
-
Dalian, Liaoning, China
- Active, not recruiting
- Zhongshan Hospital Affiliated to Dalian University
-
Shenyang, Liaoning, China
- Active, not recruiting
- Shengjing Hospital of China Medical University
-
Shenyang, Liaoning, China
- Active, not recruiting
- The First Hospital of China Medical University
-
Shenyang, Liaoning, China
- Active, not recruiting
- Central Hospital Affiliated to Shenyang Medical College
-
Shenyang, Liaoning, China
- Active, not recruiting
- Liaoning Provincial People's Hospital
-
-
Nanyang
-
Henan, Nanyang, China
- Active, not recruiting
- Nanyang Second People's Hospital
-
-
Shandong
-
Heze, Shandong, China
- Active, not recruiting
- Heze Municipal Hospital
-
Jinan, Shandong, China
- Active, not recruiting
- Jinan Central Hospital
-
Jinan, Shandong, China
- Active, not recruiting
- Qilu Hospital of Shandong University
-
Jinan, Shandong, China
- Active, not recruiting
- Shandong province Qianfoshan hospital
-
Linyi, Shandong, China
- Active, not recruiting
- Linyi People's Hospital
-
Tai'an, Shandong, China
- Active, not recruiting
- Tai'an City Central Hospital
-
Zibo, Shandong, China
- Active, not recruiting
- Zibo Municipal Hospital
-
-
Shangdong
-
Jining, Shangdong, China
- Active, not recruiting
- Affiliated Hospital of Jining Medical College
-
Jining, Shangdong, China
- Active, not recruiting
- Jining First People's Hospital
-
Zaozhuang, Shangdong, China
- Active, not recruiting
- Zaozhuang Municipal Hospital
-
-
Shanghai
-
Shanghai, Shanghai, China
- Active, not recruiting
- Putuo District Central Hospital of Shanghai
-
Shanghai, Shanghai, China
- Active, not recruiting
- Shanghai Baoshan District Wusong Central Hospital
-
-
Shanxi
-
Taiyuan, Shanxi, China
- Active, not recruiting
- The First Hospital of Shanxi Medical University
-
Taiyuan, Shanxi, China
- Active, not recruiting
- Shanxi Provincial Cardiovascular Hospital
-
Xi'an, Shanxi, China
- Active, not recruiting
- The First Affiliated Hospital of Xi 'an Jiaotong University
-
Xi'an, Shanxi, China
- Active, not recruiting
- Xi'an Gaoxin Hospital
-
Xianyang, Shanxi, China
- Active, not recruiting
- Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine
-
Xianyang, Shanxi, China
- Active, not recruiting
- Xianyang First People's Hospital
-
Xianyang, Shanxi, China
- Active, not recruiting
- Xianyang Hospital of Yan 'an University
-
-
Sichuan
-
Chengdu, Sichuan, China
- Active, not recruiting
- The Fifth People's Hospital of Chengdu
-
Mianyang, Sichuan, China
- Active, not recruiting
- Mianyang Central Hospital
-
-
Yunnan
-
Dali, Yunnan, China
- Active, not recruiting
- The First Affiliated Hospital of Dali University
-
Kunming, Yunnan, China
- Active, not recruiting
- Fuwai Yunnan Cardiovascular Hospital
-
Kunming, Yunnan, China
- Active, not recruiting
- The First People's Hospital of Yunnan Province
-
-
Zhejiang
-
Hangzhou, Zhejiang, China
- Active, not recruiting
- The First Affiliated Hospital , Zhejiang University School of Medicine
-
Hangzhou, Zhejiang, China
- Active, not recruiting
- The Second Affiliated Hospital of Zhejiang University School of Medicine
-
Hanzhou, Zhejiang, China
- Active, not recruiting
- Affiliated Hospital of Hangzhou Normal University
-
Hanzhou, Zhejiang, China
- Active, not recruiting
- Sir Run Run Shaw Hospital
-
Jiaxing, Zhejiang, China
- Active, not recruiting
- Jiaxing First Hospital
-
Ningbo, Zhejiang, China
- Active, not recruiting
- Ningbo Huamei Hospital, University of Chinese Academy of Sciences (Ningbo Second Hospital)
-
Ningbo, Zhejiang, China
- Active, not recruiting
- The First Hospital of Ningbo
-
Wenzhou, Zhejiang, China
- Active, not recruiting
- First Affiliated Hospital of Wenzhou Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18-75 years, male or female;
- Definite diagnosis of heart failure for 6 months or more, current stable disease, NYHA class II-III, left ventricular ejection fraction (LVEF) ≤ 40%(echocardiographic modified Simpson's method measurement ≤ 40% at screening, and CMR measurement ≤ 40% at baseline);
- NT-proBNP ≤1700 pg/ml in males and ≤4000pg/ml in females (detected by Roche kit in central laboratory);
- Receiving standard basic treatment for heart failure for at least 3 months, and did not change the type and dose of heart failure treatment drugs within 1 month;
- Understand and sign the informed consent form.
Exclusion Criteria:
- Unable to receive CMR examination, such as patients with pacemakers, ICDs, CRTs, or other similar devices contraindicated for CMR, claustrophobia, atrial fibrillation during the screening period, or inability to cooperate with air-closed activities required for CMR testing;
- Hypertrophic cardiomyopathy with left ventricular outflow tract obstruction, constrictive pericarditis, significant and uncorrected valvular heart disease, severe valvular regurgitation or severe stenosis, congenital heart disease requiring surgical treatment but not surgical treatment, primary pulmonary hypertension or secondary severe pulmonary hypertension (≥ 70 mmHg), and right heart failure due to pulmonary disease;
- Patients suffering from proliferative glands or adenomas with endocrine activity which may affect cardiac function or endocrine function, such as pheochromocytoma, thyromegaly, etc. (patients with euthyroid thyroid nodules do not need to be excluded);
- LVESVi less than 135 ml/m2 at baseline;
- Prepare to install pacemaker, ICD, CRT or other similar devices within 6 months;
- History of heart transplantation, use of ventricular assist devices (VADs) or preparation for heart transplantation, VADs;
- Diagnosis of peripartum or chemotherapy-induced cardiomyopathy within the past 12 months;
- Subjects with chronic heart failure with acute hemodynamic disturbance or acute decompensation within the past 1 month (symptoms and signs prove that chronic heart failure is aggravated and intravenous drug therapy is required);
- Angina pectoris within the past 3 months;
- Myocardial infarction, cerebrovascular accident, revascularization (PCI or other surgery), cardiac surgery, carotid artery or other large vessel surgery within the past 6 months;
- Serious ventricular arrhythmias (sustained ventricular tachycardia or other conditions that the investigator considers necessary to exclude);
- Clinical diagnosis of pericardial effusion, pleural effusion or imaging showed pericardial effusion (greater than 50ml or 3 mm or a small amount or more) or pleural effusion (greater than 200ml or 10 mm);
- Liver and kidney dysfunction and chronic liver disease may have a potential impact on liver function (such as active chronic hepatitis, etc.), non-heart failure causes of bilirubin or alkaline phosphatase > 2 times the upper limit of normal, aspartate aminotransferase and/or alanine aminotransferase > 3 times the upper limit of normal, eGFR calculated using MDRD method < 30 ml/min/1.73 m2;
- Systolic blood pressure < 90 mmHg or > 160 mmHg;
- Serum K + < 3.2 mmol/L or > 5.5 mmol/L;
- Women of childbearing potential who plan to become pregnant within 2 years (women of childbearing potential are defined as all women with physical ability to become pregnant), pregnant or lactating women;
- Previous history of cancer or current cancer, or pathological examination confirmed precancerous lesions (Such as ductal carcinoma in situ of the breast, or atypical hyperplasia of the cervix), or through the examination (physical examination, X-ray examination or B ultrasound examination or other means) found in vivo malignant mass subjects;
- The investigator judges that the survival time is expected to be less than 6 months;
- Participated in any drug clinical trials within the first 3 months;
- Severe neurological disease (Alzheimer's disease, progressive parkinsonism);
- Subjects who are unable to complete this study or fail to comply with the requirements of this study (due to administrative reasons or other reasons), as judged by the investigator.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Investigational drug group
Neucardin+standard basic therapeutic medication
|
10 days IV infusion of 0.6 ug/kg/day
Other Names:
|
Placebo Comparator: placebo group
Placebo + standard basic therapeutic medication
|
10 days IV infusion of 0 ug/kg/day
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Response rate at 35 days of simultaneous reduction of LVESVI and LVEDVI by more than or equal to 20 ml/m2 (The proportion of the subjects achieving this criterion in each treatment group)
Time Frame: Day 35
|
Response rate at 35 days of simultaneous reduction of LVESVI and LVEDVI by more than or equal to 20 ml/m2 (The proportion of the subjects achieving this criterion in each treatment group)
|
Day 35
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Response rate at 35 day of left ventricular end systolic volume index (LVESVI) improvement greater than or equal to 25 ml/m2;
Time Frame: Day 35
|
Response rate at 35 day of LVESVI improvement greater than or equal to 25 ml/m2;
|
Day 35
|
Response rate at 35 day of left ventricular end diastolic volume index (LVEDVI) improvement greater than or equal to 25 ml/m2;
Time Frame: Day 35
|
Response rate at 35 day of LVEDVI improvement greater than or equal to 25 ml/m2;
|
Day 35
|
Change from baseline in left ventricular ejection fraction (LVEF) at 35 days;
Time Frame: Day 35
|
Change from baseline in LVEF at 35 days;
|
Day 35
|
Change from baseline in left ventricular end systolic volume (LVESV) at 35 days;
Time Frame: Day 35
|
Change from baseline in LVESV at 35 days;
|
Day 35
|
Change from baseline in left ventricular end diastolic volume (LVEDV) at 35 days;
Time Frame: Day 35
|
Change from baseline in LVEDV at 35 days;
|
Day 35
|
Change from baseline in LVESVI and LVEDVI at 35 days;
Time Frame: Day 35
|
Change from baseline in LVESVI and LVEDVI at 35 days;
|
Day 35
|
90-day response rate of LVESVI improved greater than or equal to 25 ml/m2;
Time Frame: Day 90
|
90-day response rate of LVESVI improved greater than or equal to 25 ml/m2;
|
Day 90
|
90-day response rate of LVEDVI improved greater than or equal to 25 ml/m2;
Time Frame: Day 90
|
90-day response rate of LVEDVI improved greater than or equal to 25 ml/m2;
|
Day 90
|
90-day response rate of LVESVI and LVEDVI improved greater than or equal to 20 ml/m2 at the same time;
Time Frame: Day 90
|
90-day response rate of LVESVI and LVEDVI improved greater than or equal to 20 ml/m2 at the same time;
|
Day 90
|
Change from baseline in LVEF at 90 days;
Time Frame: Day 90
|
Change from baseline in LVEF at 90 days;
|
Day 90
|
Change from baseline in LVESV at 90 days;
Time Frame: Day 90
|
Change from baseline in LVESV at 90 days;
|
Day 90
|
Change from baseline in LVEDV at 90 days;
Time Frame: Day 90
|
Change from baseline in LVEDV at 90 days;
|
Day 90
|
Change from baseline in LVESVI and LVEDVI at 90 days;
Time Frame: Day 90
|
Change from baseline in LVESVI and LVEDVI at 90 days;
|
Day 90
|
Change from baseline in New York Heart Association (NYHA) at 35 and 90 days;
Time Frame: Day 35 and Day 90
|
Change from baseline in NYHA at 35 and 90 days;
|
Day 35 and Day 90
|
Change from baseline in quality of life at 35 and 90 days;
Time Frame: Day 35 and Day 90
|
Change from baseline in quality of life at 35 and 90 days;The benefit of patients is reflected by the quality of life score table.
|
Day 35 and Day 90
|
Mortality during the study period;
Time Frame: Through study completion, an estimation of average of 1 year
|
Mortality during the study period;
|
Through study completion, an estimation of average of 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jian Zhang, M.D, Chinese Academy of Medical Sciences, Fuwai Hospital
- Principal Investigator: Mulei Chen, M.D, Beijing Chaoyang Hospital affiliated to Capital Medical University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZS-01-308B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Systolic Heart Failure
-
Zensun Sci. & Tech. Co., Ltd.Active, not recruitingChronic Systolic Heart FailureChina
-
Zensun Sci. & Tech. Co., Ltd.TerminatedChronic Systolic Heart FailureChina
-
Jiangsu HengRui Medicine Co., Ltd.UnknownChronic Systolic Heart FailureChina
-
University of AarhusAarhus University Hospital Skejby; Central Jutland Regional HospitalCompletedChronic Systolic Heart FailureDenmark
-
Imperial College LondonUnknownChronic Systolic Heart FailureUnited Kingdom
-
University of VirginiaUnknownChronic Systolic Heart Failure | Paroxysmal VTUnited States
-
University Medicine GreifswaldDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)RecruitingChronic Heart FailureGermany
-
Zensun Sci. & Tech. Co., Ltd.Terminated
-
The Cleveland ClinicTerminatedChronic Systolic Heart Failure (Dilated Cardiomyopathy)United States
-
Central Hospital, Nancy, FranceUnknown
Clinical Trials on Neucardin
-
Zensun Sci. & Tech. Co., Ltd.RecruitingChronic Heart FailureChina
-
Zensun Sci. & Tech. Co., Ltd.Active, not recruitingChronic Systolic Heart FailureChina
-
Zensun Sci. & Tech. Co., Ltd.Zensun USA Inc.CompletedChronic Heart FailureUnited States